Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Editorial

Diet in the pathophysiology and management of irritable bowel syndrome

Magdy El-Salhy, MD, PhD
Cleveland Clinic Journal of Medicine September 2016, 83 (9) 663-664; DOI: https://doi.org/10.3949/ccjm.83a.16019
Magdy El-Salhy
Overlege/Professor, Professor of Medicine/Consultant Gastroenterologist, Head, Section for Gastroenterology, Stord Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Diet plays an important role in the pathophysiology of irritable bowel syndrome (IBS) and is an effective tool in managing this disorder. This includes a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs).

See related article, page 655

These indigestible and poorly absorbed short-chain carbohydrates trigger IBS symptoms and are thought to exert their effects by increasing osmotic pressure in the lumen of the intestine and by providing a substrate for bacterial fermentation with consequent gas production.1 The gas causes abdominal distention, and the change in pressure in the lumen of the large intestine affects the release of serotonin, causing abdominal pain and discomfort.

THE MECHANISMS ARE COMPLICATED

Recent studies have shown that the mechanisms by which FODMAPs exert their effects are more complicated than originally thought.1

All segments of the gastrointestinal tract contain endocrine cells scattered between the mucosal epithelial cells facing the intestinal lumen.1,2 There are at least 10 types of endocrine cell, and they regulate gastrointestinal motility, secretion, absorption, visceral sensitivity, local immune defense, cell proliferation, and appetite.2–4 Abnormal densities of gastrointestinal endocrine cells have been reported in patients with IBS, which may explain the dysmotility, visceral hypersensitivity, and abnormal intestinal secretion seen in these patients.5

But other factors such as diet, intestinal microbiota, genetics, and low-grade inflammation also play pivotal roles in the pathophysiology of IBS by exerting effects on gastrointestinal endocrine cells. The abnormalities in the gastrointestinal endocrine cells in IBS are thought to be brought about by aberrant differentiation of stem cells into endocrine cells (Figure 1).6

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Symptoms of irritable bowl syndrome are believed to be triggered by the consumption of a diet rich in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) via mechanisms involving the intestinal endocrine cells. FODMAPs act as prebiotics, providing a substrate selecting unfavorable bacteria, resulting in the fermentation of FODMAPs. The by-products of the interaction between FODMAPs and intestinal microbiota act on intestinal stem cells, resulting in abnormal clonogenic activity and differentiation progeny. Abnormal stem cell activity leads to an altered density of endocrine cells, causing gastrointestinal dysmotility, visceral hypersensitivity, and abnormal intestinal secretion.

A diet low in FODMAPs appears to induce changes in the intestinal microbiota and gastrointestinal endocrine cells and to reduce IBS symptoms.6

GLUTEN IS IMPLICATED

Another dietary factor in IBS is gluten. Symptoms of IBS and celiac disease overlap: most studies have found that fewer than 5% of patients with celiac disease are misdiagnosed as having IBS based on the symptom criteria for IBS, but some studies report a rate as high as 32%.7 In addition, 38% of patients with celiac disease who consume a gluten-free diet fulfill the symptom-based Rome criteria for IBS.7

The contribution of gluten to IBS does not end with the coexistence of IBS and celiac disease, but also includes the newly debated diagnosis of nonceliac gluten sensitivity, characterized by gastrointestinal symptoms (abdominal pain, diarrhea, constipation, nausea, and vomiting) and other symptoms (headache, musculoskeletal pain, “brain fog,” fatigue, and depression) that are similar to those of IBS. Symptoms are triggered by the ingestion of wheat products, are improved after wheat products are removed from the diet, and relapse after a wheat challenge.7

Nonceliac gluten sensitivity is often perceivable by patients, resulting in self-diagnosis and self-treatment.4 However, it is not clear whether it is gluten or the fructans and galactans in wheat that are responsible for triggering their symptoms.7

DIETARY GUIDANCE IS NEEDED

A low-FODMAP diet with small amounts of insoluble dietary fiber improves symptoms and quality of life in patients with IBS, but dietary guidance is critical and should be personalized because patients differ in how they tolerate foods rich in FODMAPs, probably owing to differing intestinal microbiota among individuals.3,8 Intake of probiotics increases tolerance of FODMAP-rich foods and should also be recommended.3,8,9 Because of the rigorous restrictions of the low-FODMAP diet, patients who receive personalized guidance are more inclined to adhere to the diet and to avoid vitamin and mineral deficiencies.9

  • Copyright © 2016 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. El-Salhy M,
    2. Gundersen D
    . Diet in irritable bowel syndrome. Nutr J 2015; 14:36–46.
    OpenUrl
  2. ↵
    1. El-Salhy M,
    2. Seim I,
    3. Chopin L,
    4. Gundersen D,
    5. Hatlebakk JG,
    6. Hausken T
    . Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front Biosci (Elite Ed) 2012; 4:2783–2800.
    OpenUrl
  3. ↵
    1. El-Salhy M,
    2. Gundersen D,
    3. Hatlebakk JG,
    4. Hausken T
    . Irritable bowel syndrome: diagnosis, pathogenesis and treatment options. 1st ed. New York, NY: Nova Science Publishers, Inc.; 2014.
  4. ↵
    1. El-Salhy M,
    2. Ostgaard H,
    3. Gundersen D,
    4. Hatlebakk JG,
    5. Hausken T
    . The role of diet in the pathogenesis and management of irritable bowel syndrome (review). Int J Mol Med 2012; 29:723–731.
    OpenUrlPubMed
  5. ↵
    1. El-Salhy M,
    2. Gundersen D,
    3. Gilja OH,
    4. Hatlebakk JG,
    5. Haus-ken T
    . Is irritable bowel syndrome an organic disorder? World J Gastroenterol 2014; 20:384–400.
    OpenUrl
  6. ↵
    1. El-Salhy M
    . Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2015; 21:7621–7636.
    OpenUrlCrossRefPubMed
  7. ↵
    1. El-Salhy M,
    2. Hatlebakk JG,
    3. Gilja OH,
    4. Hausken T
    . The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutr J 2015; 14:92–99.
    OpenUrl
  8. ↵
    1. El-Salhy M,
    2. Lillebo E,
    3. Reinemo A,
    4. Salmelid L,
    5. Hausken T
    . Effects of a health program comprising reassurance, diet management, probiotic administration and regular exercise on symptoms and quality of life in patients with irritable bowel syndrome. Gastroenterology Insights 2010; 2:21–26. doi:http://dx.doi.org/10.4081/gi/2010.e6.
    OpenUrl
  9. ↵
    1. Ostgaard H,
    2. Hausken T,
    3. Gundersen D,
    4. El-Salhy M
    . Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep 2012; 5:1382–1390.
    OpenUrl
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 83 (9)
Cleveland Clinic Journal of Medicine
Vol. 83, Issue 9
1 Sep 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diet in the pathophysiology and management of irritable bowel syndrome
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Diet in the pathophysiology and management of irritable bowel syndrome
Magdy El-Salhy
Cleveland Clinic Journal of Medicine Sep 2016, 83 (9) 663-664; DOI: 10.3949/ccjm.83a.16019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Diet in the pathophysiology and management of irritable bowel syndrome
Magdy El-Salhy
Cleveland Clinic Journal of Medicine Sep 2016, 83 (9) 663-664; DOI: 10.3949/ccjm.83a.16019
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • THE MECHANISMS ARE COMPLICATED
    • GLUTEN IS IMPLICATED
    • DIETARY GUIDANCE IS NEEDED
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Managing irritable bowel syndrome: The low-FODMAP diet
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The beat goes on: Highlights from the new American and European A-fib guidelines
  • Subclinical hypothyroidism: What’s in a name?
  • Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
Show more Editorial

Similar Articles

Subjects

  • Gastroenterology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire